On Biostatistics and Clinical Trials
CQ's web blog on the issues in biostatistics and clinical trials.
Showing posts with label
resubmission
.
Show all posts
Showing posts with label
resubmission
.
Show all posts
Friday, June 02, 2023
Resubmission of NDA/BLA After CRL: Class 1 versus Class 2 resubmission
›
If new drug application (NDA) or biological license application (BLA) is not approved by the FDA, the sponsor will receive a complete respon...
›
Home
View web version
